BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30971541)

  • 21. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
    Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
    Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical Expression of HBME-1 and TROP-2 in Some Follicular-Derived Thyroid Lesions.
    Abu-Seadah SS; Attiah SM; Ali MY; Shams El-Din M; El-Kholy MA
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2305-2311. PubMed ID: 37505760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive DNA Methylation Profiling Identifies Novel Diagnostic Biomarkers for Thyroid Cancer.
    Park JL; Jeon S; Seo EH; Bae DH; Jeong YM; Kim Y; Bae JS; Kim SK; Jung CK; Kim YS
    Thyroid; 2020 Feb; 30(2):192-203. PubMed ID: 31797753
    [No Abstract]   [Full Text] [Related]  

  • 25. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
    Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
    [No Abstract]   [Full Text] [Related]  

  • 26. [Follicular cell (papillary and follicular) thyroid carcinoma, genetic inheritance, and molecular diagnostic markers].
    Kazubskaia TP; Kozlova VM; Kondrat'eva TT; Pavlovskaia AI; Marakhonov AV; Baranova AV; Ivanova NI; Stepanova AA; Poliakov AV; Belev NF; Brzhezovskiĭ VZh
    Arkh Patol; 2014; 76(5):3-12. PubMed ID: 25543402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
    Hirokawa M; Higuchi M; Suzuki A; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2020 Oct; 67(10):1071-1075. PubMed ID: 32595200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
    Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
    Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An antibody-like peptide that recognizes malignancy among thyroid nodules.
    Reis CF; Carneiro AP; Vieira CU; Fujimura PT; Morari EC; Silva SJ; Goulart LR; Ward LS
    Cancer Lett; 2013 Jul; 335(2):306-13. PubMed ID: 23462224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound features and risk stratification system in NIFT-P and other follicular-patterned thyroid tumors.
    Matrone A; Gambale C; Pieroni E; De Napoli L; Torregrossa L; Materazzi G; Elisei R
    Eur J Endocrinol; 2023 Aug; 189(2):175-182. PubMed ID: 37530386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis.
    Keelawat S; Thorner PS; Shuangshoti S; Bychkov A; Kitkumthorn N; Rattanatanyong P; Boonyayothin W; Poumsuk U; Ruangvejvorachai P; Mutirangura A
    J Endocrinol Invest; 2015 Jul; 38(7):725-32. PubMed ID: 25740063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
    Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
    Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP.
    Tastekin E; Keskin E; Can N; Canberk S; Mut A; Erdogan E; Asa N; Güldiken S; Sezer A; Azatcam M
    Pol J Pathol; 2019; 70(4):286-294. PubMed ID: 32146798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
    Sadiq Q; Sekhri R; Dibaba DT; Zhao Q; Agarwal S
    World J Surg Oncol; 2021 May; 19(1):143. PubMed ID: 33964951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion.
    Takagi S; Hirokawa M; Nagashima K; Higuchi M; Kadota K; Ishikawa R; Sato M; Miyauchi A; Miyake Y; Haba R
    Endocr J; 2020 Dec; 67(12):1207-1214. PubMed ID: 32879160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
    Fan YL; Li XQ
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Value of TROP2 Expression in Papillary Thyroid Carcinoma.
    Saffar H; Jahanbin B; Ameli F; Farhang F; Tavangar SM; Saffar H
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):218-222. PubMed ID: 33264108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytologic features of focal papillary thyroid carcinoma arising within follicular adenoma: a masked cytomorphologic analysis of 17 cases.
    Ono JC; Wilbur DC; Lee H; Yang J; Krane JF; Bongiovanni M; Faquin WC
    Acta Cytol; 2011; 55(6):531-8. PubMed ID: 22156462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.